DIBENZYLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dibenzyline, and when can generic versions of Dibenzyline launch?
Dibenzyline is a drug marketed by Concordia and is included in one NDA.
The generic ingredient in DIBENZYLINE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dibenzyline
A generic version of DIBENZYLINE was approved as phenoxybenzamine hydrochloride by ENDO OPERATIONS on January 24th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIBENZYLINE?
- What are the global sales for DIBENZYLINE?
- What is Average Wholesale Price for DIBENZYLINE?
Summary for DIBENZYLINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 34 |
| Clinical Trials: | 5 |
| Patent Applications: | 3,291 |
| Drug Prices: | Drug price information for DIBENZYLINE |
| What excipients (inactive ingredients) are in DIBENZYLINE? | DIBENZYLINE excipients list |
| DailyMed Link: | DIBENZYLINE at DailyMed |
Recent Clinical Trials for DIBENZYLINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| NorthShore University HealthSystem | Phase 3 |
| University of California, Los Angeles | Phase 3 |
| Vanderbilt University | Phase 2 |
Pharmacology for DIBENZYLINE
| Drug Class | alpha-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Antagonists |
US Patents and Regulatory Information for DIBENZYLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concordia | DIBENZYLINE | phenoxybenzamine hydrochloride | CAPSULE;ORAL | 008708-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
